Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azenta, Inc.BRKS · Entity 4724 | President-Brooks Life Sciences | February 15, 2019 | February 15, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azenta, Inc.
Report date February 15, 2019 · Filed February 15, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 136,556 |
Reported balance
After 2019-02-15 transaction · row 1
1 source rowRow 1 · 2019-02-15 · Sale · Disposed 10,204 · Balance 136,556 F1: Represents the weighted average price for the shares sold. The shares were sold at per-share prices ranging from $32.50 to $32.70. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average price for the shares sold. The shares were sold at per-share prices ranging from $32.50 to $32.70. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 15, 2019 21:59 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 10,204 | $32.51 | $331,732.04 |
DisclosureSEC source: 0001209191-19-010678 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,556 F1 · price: Represents the weighted average price for the shares sold. The shares were sold at per-share prices ranging from $32.50 to $32.70. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 22:21 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 7,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060613 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,760 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2019. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:35 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 3,461 | $28.59 | $98,949.99 |
DisclosureSEC source: 0001209191-18-059441 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,969 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2018 of 7,546 restricted stock units from two grants (5,333 and 2,213, respectively) held by the reporting person. F2 · price: This represents the weighted average price for shares sold at a range between $28.58 and $28.94. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 21:44 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 46,487 | $30.93 | $1,437,842.91 |
DisclosureSEC source: 0001209191-18-058552 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,430 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 6, 2018 of 103,140 restricted stock units held by the reporting person. F2 · price: This represents the weighted average price for shares sold between November 7, 2018 and November 12, 2018 at a range between $28.00 and $32.35. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 06, 2018 Filed Nov 7, 2018 22:18 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 43,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-057640 · doc4.xml · nonDerivative · entry 2 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,917 F2 · shares: An initial grant of 80,000 restricted stock units (RSUs) was received on November 4, 2015 and reported on Form 4 dated November 6, 2015. The grant contained 60,000 performance-based units subject to performance-based vesting requirements, measured at the three-year period ended September 30, 2018, resulting in the achievement of 171.9%, or 103,140 of the performance-based units. This transaction represents a grant of an additional 43,140 RSUs. No amount was paid upon grant of RSUs. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:18 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 2,052 | $31.76 | $65,171.52 |
DisclosureSEC source: 0001209191-18-057640 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,777 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 4, 2018 of 6,668 restricted stock units held by the reporting person. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:13 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 8,969 | $29.80 | $267,276.20 |
DisclosureSEC source: 0001209191-18-031396 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,829 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $29.75 to $29.85. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 21, 2018 Filed Mar 22, 2018 20:28 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0001209191-18-021254 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,798 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| January 19, 2018 Filed Jan 22, 2018 21:42 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 10,000 | $28.00 | $280,000.00 |
DisclosureSEC source: 0001209191-18-004734 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,798 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 21:35 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 2,550 | $27.13 | $69,181.50 |
DisclosureSEC source: 0001209191-17-061790 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,798 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2017 of 5,333 restricted stock units held by the reporting person. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 23:06 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 13,337 | $28.55 | $380,771.35 |
DisclosureSEC source: 0001209191-17-060432 · doc4.xml · nonDerivative · entry 3 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,348 F3 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 8, 2017 of 23,541 restricted stock units held by the reporting person. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 23:06 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060432 · doc4.xml · nonDerivative · entry 2 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,685 F2 · shares: An initial grant of 75,000 restricted stock units (RSUs) was received on November 5, 2014 and reported on Form 4 dated November 6, 2014. The grant contained 22,500 performance-based units subject to performance-based vesting requirements, measured at the three-year period ended September 30, 2017, resulting in the achievement of 104.63%, or 23,541 of the performance-based units. This transaction represents a grant of an additional 1,041 RSUs. No amount was paid upon grant of RSUs. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 23:06 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 6,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060432 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,664 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2018. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:21 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 13,788 | $33.80 | $466,034.40 |
DisclosureSEC source: 0001209191-17-059749 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,007 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 4, 2017 of 31,666 restricted stock units and with the vesting on November 5, 2017 of 6,251 restricted stock units held by the reporting person. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 21:22 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 5,000 | $16.52 | $82,600.00 |
DisclosureSEC source: 0001209191-16-154151 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,795 F1 · price: Represents the weighted average price for the shares sold. Shares in the amount of 2,500 were sold at $16.50 and another 2,500 shares were sold at $16.55 Read SEC document |
| November 16, 2016 Filed Nov 21, 2016 13:37 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 15,117 | $15.35 | $232,045.95 |
DisclosureSEC source: 0001209191-16-151333 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,795 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2016 of 37,915 restricted stock units held by the reporting person. Read SEC document |
| November 09, 2016 Filed Nov 15, 2016 00:41 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149970 · doc4.xml · nonDerivative · entry 1 Tenney Maurice H. · CIK 0001539741 · President-Brooks Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,912 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2017. F2 · balance_after: The amount of securities beneficially owned reflects the forfeiture of 33,750 performance-based units that were subject to performance-based vesting requirements based on achievement of performance criteria measured for the one-year period ended September 30, 2015, which resulted in no vesting of such performance based RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.